BackTalaris Therapeutics Overview

Talaris Therapeutics Selling, General & Admin

Selling, General & Admin expenses for TALS.

Quarterly SG&A Expenses

$6.34M
↑ 1.65% YoY

As of Jun 30, 2025

Annual SG&A Expenses (TTM)

$18.85M
↓ 31.62% YoY

Trailing 12 months ending Jun 30, 2025

Average SG&A Expenses (Comparison Companies)

Selling, General & Admin History

Selling, General & Admin Comparison

Annual Selling, General & Admin Growth Rate (%)

Annual Selling, General & Admin Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin